Medra
Medra58
About
What does Medra do?
Medra develops Physical AI Scientists that autonomously conduct biological experiments using robotics and AI. The platform integrates scientific reasoning with physical execution, enabling continuous learning and faster iteration in drug discovery. It aims to accelerate the development of therapeutics by creating a closed-loop system for hypothesis generation, experimental validation, and optimization.
What is Medra's valuation?
StartupHub estimates Medra's effective valuation at $256.8M (range $157.5M to $378.0M, 20% confidence), based on comparable companies in the sector.
How much funding has Medra raised?
Medra has raised a total of $63M in funding. The most recent round on record is Series A.
Where is Medra headquartered?
Medra is headquartered in San Francisco, United States.
When was Medra founded?
Medra was founded in 2021.
What industry does Medra operate in?
Medra operates in Healthcare AI, Clinical Documentation, Biotech, HealthTech, Robotics, Drug Discovery.
How many employees does Medra have?
Medra has approximately 20 people on record.
AI-powered ambient documentation for modern clinics.
A tamper-evident, independently verifiable audit trail for clinical AI agents, enforcing policy before action.
AI-driven platform for anonymizing and synthesizing sensitive healthcare data while preserving utility.
An entrant is a company tagged Healthcare AI whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.